Purpose
Biological infrastructure for resilient ocean protein.
Oyster Genomics builds the genetic operating infrastructure for commercial aquaculture, so ocean farming can run as predictable, programmable bio-manufacturing.
Problem
Aquaculture still runs on wild genetics.
The sector already produces more than half the world’s seafood. It is a $300B+ market, expanding faster than any other animal protein. The germplasm underneath it was never domesticated.
Catastrophic crop failure
Coastal nurseries and grow-out sites routinely lose 70–80% of a crop to endemic pathogens, including Perkinsus marinus (Dermo).
A breeding deadlock
Bivalve immunity sits in structural variation and phase-variable promoter inversions. Phenotypic selection takes 5–7 years a cycle and does not fix that multi-locus architecture.
Capital stays out
High mortality forces farmers to over-seed, compresses farm-level margins, and keeps institutional debt and insurance out of the asset class.
Switchpoint
Structural variants, found and fixed.
Switchpoint™ reads the bivalve genome as dynamic, rewritable circuitry. The work is the regulatory node, and the product is a parent line that already carries it.
Zero-shot structural mining
Chromosome-scale assemblies and long-read structural-variant maps locate the regulatory nodes that control innate immunity and growth.
Monogenic immune acceleration
Loss-of-function targets such as the SOCS6 R263 checkpoint remove the delay in innate immune activation, so big defensin and TRIM defenses engage before a pathogen reaches systemic load.
Manufacturing tolerance
Homozygous parental lines carry the structural allele fixed. Juvenile spat challenge assays compress a genetic cycle from years to months.
Why now
The genome is finally readable at this resolution.
Three conditions arrived together: complete structural-variant maps, models that can score a regulatory edit directly, and a coast where wild seed no longer pays.
Chromosome-scale assemblies
High-fidelity long reads now resolve structural variants across marine bivalves.
Zero-shot foundation models
Generative biological models predict regulatory effect directly, ahead of a multi-generation trial.
Coastal supply shocks
Marine heatwaves and pathogen surges have made wild seed uneconomic for commercial operators.
Market
Aquaculture is the next agtech market.
Eastern oyster is the first commercial door. The same structural-variant pipeline extends into the largest marine proteins.
$300B+
Global aquaculture market.
$12B+
Global mollusk and bivalve market.
$450M
Eastern oyster (Crassostrea virginica) commercial seed and breeding across the US East Coast and Gulf.
Shrimp
$40B+
Salmon
$20B+
Tilapia
$12B+
Architecture
Platform, broodstock, hatchery, farm.
Switchpoint finds the allele. Apex lines hold it. Licensed hatcheries turn it into seed. Farms harvest a uniform animal.
Switchpoint™
Maps cryptic structural variants and phase-variable regulatory nodes.
Apex homozygous broodstock
Proprietary tetraploid and diploid parent lines holding fixed immune alleles, including SOCS6.
Commercial hatchery network
Licensed hatcheries mate OG lines and produce sterile triploid seed.
Grow-out farms
Target harvest survival above 90%, against a wild baseline under 20%. Uniform, market-sized animals.
96.2%
Survival in controlled lethal pathogen challenges.
<15%
Survival in the same challenge.
The targets use native structural-variant architecture. The lines are non-transgenic, and sit outside the FDA CVM transgenic-animal framework.
Model
Genetics-as-a-service.
Hatcheries license elite genetics and sell the seed. Oyster Genomics is paid on access, and again on every thousand units that leave the hatchery.
An upfront integration and access fee secures regional distribution rights to apex parent lines.
A fixed royalty on every thousand units of sterile triploid seed sold to farmers.
Commercial seed is sterile triploid. The line cannot be back-crossed or held as broodstock on the farm. Every planting cycle starts with a fresh purchase from a licensed hatchery.
Defensibility
Sterile seed, and a data flywheel.
The commercial animal cannot reproduce the product. Each challenge assay sends survival data back into Switchpoint™ and sharpens the next call, including in later species.
Method
Traditional broodstock
Multi-generation phenotype selection.
Agri-biotech giants
Transgenics and row-crop programs. Coastal aquaculture is outside the portfolio.
Oyster Genomics
Zero-shot structural variant editing.
Cycle time
Traditional broodstock
5–7 years per line.
Agri-biotech giants
No coastal aquaculture cycle.
Oyster Genomics
Under 12 months to a validated spat line.
IP moat
Traditional broodstock
None. A farmer can reproduce the animal.
Agri-biotech giants
Patents and contracts.
Oyster Genomics
Biological lock. Sterile triploid seed.
Focus
Traditional broodstock
Low-tech and academic breeding programs.
Agri-biotech giants
Terrestrial livestock and seed.
Oyster Genomics
Marine-native structural genomics.